HIMS

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.95
Percentage change -1.81	%

Peers: ELF LFMD PRGO TDOC GDRX AMWL DOCS CLOV RXRX TWST

| Held by: IJH IWM VTI VB VXF IWO MDY VBK IJK SCHA

Scroll to Statements

Index	RUT	P/E	74.82	EPS (ttm)	0.69	Insider Own	18.02%	Shs Outstand	215.21M	Perf Week	42.15%
Market Cap	11.50B	Forward P/E	53.71	EPS next Y	0.96	Insider Trans	-5.71%	Shs Float	183.50M	Perf Month	96.93%
Income	164.40M	PEG	2.22	EPS next Q	0.15	Inst Own	71.55%	Short Float	33.06%	Perf Quarter	27.01%
Sales	1.78B	P/S	6.45	EPS this Y	21.81%	Inst Trans	-0.29%	Short Ratio	1.79	Perf Half Y	147.59%
Book/sh	2.46	P/B	20.92	EPS next Y	48.23%	ROA	24.54%	Short Interest	60.66M	Perf Year	341.20%
Cash/sh	1.44	P/C	35.66	EPS next 5Y	33.66%	ROE	36.79%	52W Range	11.64 - 72.98	Perf YTD	112.57%
Dividend Est.	-	P/FCF	48.90	EPS past 5Y	17.22%	ROI	27.00%	52W High	-29.57%	Beta	1.88
Dividend TTM	-	Quick Ratio	1.32	Sales past 5Y	62.28%	Gross Margin	68.19%	52W Low	341.58%	ATR (14)	4.38
Dividend Ex-Date	-	Current Ratio	1.59	EPS Y/Y TTM	6218.70%	Oper. Margin	6.48%	RSI (14)	75.01	Volatility	14.64% 10.63%
Employees	1637	Debt/Eq	0.12	Sales Y/Y TTM	85.99%	Profit Margin	9.21%	Recom	2.56	Target Price	46.20
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	313.81%	Payout	0.00%	Rel Volume	2.39	Prev Close	52.35
Sales Surprise	8.80%	EPS Surprise	65.43%	Sales Q/Q	110.67%	Earnings	May 05 AMC	Avg Volume	33.96M	Price	51.40
SMA20	53.70%	SMA50	52.87%	SMA200	86.49%	Trades		Volume	81,009,942	Change	-1.81%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-25	Downgrade	TD Cowen	Buy → Hold	$30
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral	$8 → $6

Show Previous Ratings

May-08-25 10:25PM	Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare (Business Wire)
07:57AM	Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare (Business Wire)
06:50AM	Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer (Business Wire)
06:30AM	Hims & Hers Has a Superpower in Healthcare (Motley Fool)
05:05AM	Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy? (Motley Fool)
10:16PM	Loading…
May-07-25 10:16PM	Hims & Hers: 2030 Guidance Indicates Big Upside (Seeking Alpha) +5.82%
12:20PM	Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock (Zacks)
11:42AM	Why Novo Nordisk Stock Popped After Earnings (Motley Fool)
11:29AM	Novo Nordisk Q1 Earnings Review: Forget Revenue Miss, Buy Semaglutide Hype (Seeking Alpha)
11:18AM	Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (Seeking Alpha)
08:45AM	Why Is Hims & Hers Stock Skyrocketing? (Motley Fool)
08:23AM	Hims & Hers Health: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) (Seeking Alpha)
07:30AM	Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth (Motley Fool)
07:12AM	Novo Nordisk cuts 2025 outlook. But why are its shares rising? (Seeking Alpha)
06:50AM	Novo Nordisk beats on Q1 earnings, cuts 2025 outlook (Yahoo Finance)
03:33AM	Loading…
03:33AM	Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday (Insider Monkey)
02:41AM	Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth (TipRanks)
12:33AM	2 Volatile Stocks Worth Your Attention and 1 to Steer Clear Of (StockStory)
May-06-25 05:22PM	Stocks Fall as Tariff Angst Spurs Gains in Bonds: Markets Wrap (Bloomberg) +18.12%
04:35PM	Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18% (Investor's Business Daily)
04:25PM	Stock Market Today: Dow Jones, S&P 500 Fall Again; Gold Stocks Rally While Palantir Tumbles (Live Coverage) (Investor's Business Daily)
03:20PM	Veracyte Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
02:32PM	Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped (Motley Fool)
01:17PM	HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition (StockStory)
01:00PM	HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down (Zacks)
12:10PM	Hims surges, SolarEdge earnings beat, Rivian expands in Illinois (Yahoo Finance Video)
11:32AM	Hims & Hers Stock Rises on Fundamentals and Squeeze Potential (MarketBeat)
10:32AM	Hims & Hers Stock Jumps as Q1 Sales More Than Double (Investopedia)
09:13AM	Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook (Investor's Business Daily)
May-05-25 07:52PM	Hims & Hers Health, Inc. (HIMS) Q1 2025 Earnings Call Transcript (Seeking Alpha)
06:30PM	Loading…
06:30PM	Here's What Key Metrics Tell Us About Hims & Hers Health (HIMS) Q1 Earnings (Zacks)
06:01PM	Trading Week Starts Out on the Soft Side (Zacks)
05:35PM	Hims & Hers Health, Inc. (HIMS) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:50PM	Hims & Hers Health Revenue Jumps, But Outlook Disappoints (The Wall Street Journal)
04:31PM	Hims & Hers stock slips on disappointing Q2 revenue outlook (Yahoo Finance Video)
04:05PM	Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results (Business Wire)
02:48PM	Progyny Stock Sees RS Rating Improve To 73 (Investor's Business Daily)
12:59PM	Hims & Hers Names New COO. Stock Rallies. (Investor's Business Daily)
12:54PM	Wall Street Lunch: Tariffs For Tinseltown (Seeking Alpha)
11:28AM	Buffett succession, Palantir earnings preview, Hims COO pick (Yahoo Finance Video)
09:01AM	Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer (Business Wire)
May-04-25 06:44AM	BUZZ: ETF Focused On Social Media Stories (Seeking Alpha)
05:38AM	Why Hims & Hers Health, Inc. (HIMS) Soared Last Week (Insider Monkey)
May-02-25 10:22PM	Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday (Insider Monkey) +12.89%
11:55AM	Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday (Motley Fool)
11:05AM	Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings? (Zacks)
10:56AM	Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings? (Zacks)
May-01-25 08:10PM	Why Hims & Hers Health, Inc. (HIMS) Soared On Thursday (Insider Monkey) +9.24%
05:45PM	IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
02:42PM	Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade' (Yahoo Finance)
11:12AM	Hims & Hers: Revolutionizing Healthcare (Seeking Alpha)
10:01AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
07:27AM	4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates (Zacks)
06:30AM	CVS posts Q1 earnings beat, raises full-year guidance (Yahoo Finance)
Apr-30-25 08:54PM	Why Hims & Hers Health, Inc. (HIMS) Soared on Tuesday (Insider Monkey) -5.54%
04:48PM	Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement? (Zacks)
12:43PM	Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now? (Zacks)
10:38AM	Hims & Hers Stock Soars on Novo Nordisk Collaboration (MarketBeat)
09:50AM	Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio (Zacks)
07:51AM	TECH Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
05:32AM	Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar? (Zacks)
05:30AM	Why New Wegovy Deals Wont Restore Novo Nordisks Obesity Lead (The Wall Street Journal)
Apr-29-25 05:12PM	Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap (Bloomberg) +23.03%
04:12PM	Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy (Investor's Business Daily)
03:27PM	Hims & Hers Health: GLP-1 Deals De-Risk The Story (Seeking Alpha)
03:19PM	Why Hims & Hers Health and LifeMD Are Skyrocketing Today (Motley Fool)
02:48PM	Hims & Hers Health (HIMS) Shares Skyrocket, What You Need To Know (StockStory)
02:29PM	Growth Is Priced Out Of Novo Nordisk (Seeking Alpha)
01:35PM	Wall Street Lunch: White House Scolds Amazon (Seeking Alpha)
12:36PM	Hims & Hers Stock Surges on Wegovy Deal With Novo Nordisk (Investopedia)
11:13AM	Hims-Novo Nordisk partnership, SoFi earnings, Spotify guidance (Yahoo Finance Video)
10:30AM	Wegovy Today, Ozempic Tomorrow: Partnership With Novo Is Hims & Hers Comeback (Seeking Alpha)
10:18AM	Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership (Yahoo Finance)
10:02AM	Hims & Hers with Novo Nordisk, Hilton, PayPal: Trending Tickers (Yahoo Finance Video)
08:12AM	Bet on Winning DuPont Analysis & Pick 3 Top Stocks (Zacks)
07:30AM	Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care (Business Wire)
Apr-28-25 05:17PM	Hims & Hers: Selling Options On This High-Growth Gem Could Yield 20% Or More (Rating Upgrade) (Seeking Alpha)
01:26PM	EMEA Growth & Product Launches to Support Boston Scientific Stock (Zacks)
11:22AM	Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings? (Zacks)
10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: Should You Buy? (Zacks)
09:19AM	HSIC Gears Up for Q1 Earnings: Here's What You Need to Know (Zacks)
09:12AM	Here's How Charles River is Placed Just Ahead of Q1 Earnings (Zacks)
08:45AM	GYN Surgical Division Likely to Drive Hologic's Q2 Earnings (Zacks)
Apr-25-25 05:45PM	Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
02:45PM	Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last (Yahoo Finance)
Apr-24-25 11:39AM	EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes (Zacks) +5.35%
Apr-23-25 11:21AM	Hims & Hers: Look Past Near-Term GLP-1 Risks, This Is A Great Dip To Buy (Seeking Alpha) +5.36%
07:38AM	BUZZ Investing: Tariff Chaos Shakes U.S. Equities (Seeking Alpha)
05:04AM	2 Reasons to Like HIMS and 1 to Stay Skeptical (StockStory)
Apr-22-25 09:00AM	Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? (Zacks)
08:39AM	Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network (Zacks)
08:13AM	Zimmer Biomet to Report Q1 Earnings: Here's What to Expect (Zacks)
07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-21-25 05:32PM	Is Hims & Hers Health, Inc. (HIMS) the Best Telehealth Stock to Buy Now? (Insider Monkey) -5.10%
12:35PM	Hims & Hers: Top Pick For The Next Decade (Seeking Alpha)
09:57AM	Will Robust Exome and Genome Growth Boost WGS' Q1 Earnings Results? (Zacks)
08:44AM	Hims & Hers Health and AST SpaceMobile have been highlighted as Zacks Bull and Bear of the Day (Zacks)
08:34AM	IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? (Zacks)
05:38AM	3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era (Zacks)
Apr-19-25 07:00AM	Oddity: Rare Beauty Gem (Seeking Alpha)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Boughton Soleil	Chief Legal Officer	Apr 28 '25	Sale	30.19	3,236	97,695	159,662	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Option Exercise	2.43	50,000	121,500	142,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Option Exercise	2.43	41,667	101,251	133,770	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 29 '25	Sale	36.39	50,000	1,819,310	92,103	Apr 30 06:01 PM
Dudum Andrew	Chief Executive Officer	Apr 28 '25	Sale	30.19	41,667	1,257,760	92,103	Apr 30 06:01 PM
Dudum Andrew	Officer	Apr 29 '25	Proposed Sale	36.39	50,000	1,819,309		Apr 29 10:51 AM
Dudum Andrew	Officer	Apr 28 '25	Proposed Sale	30.19	41,667	1,257,753		Apr 28 12:51 PM
Boughton Soleil	Officer	Apr 28 '25	Proposed Sale	30.19	3,236	97,695		Apr 28 10:07 AM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Option Exercise	1.97	33,333	65,653	838,416	Apr 23 04:21 PM
Baird Melissa	Chief Operating Officer	Apr 21 '25	Sale	25.78	33,333	859,256	805,083	Apr 23 04:21 PM
Becklund Irene	PAO	Apr 22 '25	Sale	26.49	2,936	77,775	5,071	Apr 23 04:21 PM
Becklund Irene	Officer	Apr 22 '25	Proposed Sale	26.49	2,936	77,775		Apr 22 09:46 AM
Melissa Baird	Officer	Apr 21 '25	Proposed Sale	25.84	33,333	861,325		Apr 21 04:37 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Option Exercise	2.43	33,668	81,813	128,563	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.23	47,534	1,342,094	332,728	Apr 18 03:40 PM
Dudum Andrew	Chief Executive Officer	Apr 16 '25	Sale	28.04	36,460	1,022,453	92,103	Apr 18 03:40 PM
Boughton Soleil	Chief Legal Officer	Mar 03 '25	Sale	45.14	4,151	187,376	166,134	Apr 16 04:30 PM
Boughton Soleil	Chief Legal Officer	Apr 14 '25	Sale	28.72	3,236	92,938	162,898	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Option Exercise	6.43	6,437	41,377	130,541	Apr 16 04:30 PM
Okupe Oluyemi	Chief Financial Officer	Apr 15 '25	Sale	28.50	11,581	330,082	118,960	Apr 16 04:30 PM
Dudum Andrew	Officer	Apr 16 '25	Proposed Sale	28.15	83,994	2,364,547		Apr 16 10:44 AM
Boughton Soleil	Officer	Apr 14 '25	Proposed Sale	28.72	3,236	92,938		Apr 14 09:52 AM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Option Exercise	1.75	33,337	58,340	838,420	Apr 10 04:30 PM
Baird Melissa	Chief Operating Officer	Apr 09 '25	Sale	27.32	33,337	910,687	805,083	Apr 10 04:30 PM
Melissa Baird	Officer	Apr 09 '25	Proposed Sale	29.49	33,337	983,108		Apr 09 04:42 PM
Baird Melissa	Chief Operating Officer	Apr 04 '25	Option Exercise	5.01	40,380	202,304	805,083	Apr 07 04:15 PM
Becklund Irene	PAO	Apr 03 '25	Sale	28.78	2,203	63,402	8,007	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Option Exercise	5.01	6,437	32,249	135,685	Apr 04 04:52 PM
Okupe Oluyemi	Chief Financial Officer	Apr 02 '25	Sale	29.26	11,581	338,833	124,104	Apr 04 04:52 PM
Becklund Irene	Officer	Apr 03 '25	Proposed Sale	28.78	2,203	63,402		Apr 03 10:29 AM
Baird Melissa	Chief Operating Officer	Mar 31 '25	Option Exercise	5.01	13,460	67,435	764,703	Apr 01 04:57 PM
Boughton Soleil	Chief Legal Officer	Mar 31 '25	Sale	27.77	3,236	89,864	170,285	Apr 01 04:57 PM
Boughton Soleil	Officer	Mar 31 '25	Proposed Sale	27.77	3,236	89,864		Mar 31 09:54 AM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Option Exercise	0.40	67,687	27,075	818,930	Mar 27 05:04 PM
Baird Melissa	Chief Operating Officer	Mar 26 '25	Sale	34.84	67,687	2,358,145	751,243	Mar 27 05:04 PM
Melissa Baird	Officer	Mar 26 '25	Proposed Sale	33.36	67,687	2,258,038		Mar 26 04:09 PM
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM
Chi Michael	Officer	Feb 24 '25	Proposed Sale	48.14	17,303	832,966		Feb 24 10:46 AM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Option Exercise	2.43	125,335	304,564	223,022	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.27	128,127	7,466,121	97,687	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.15	47,534	2,763,942	427,796	Feb 20 08:18 PM
Boughton Soleil	Chief Legal Officer	Feb 18 '25	Sale	60.69	4,152	251,985	157,345	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Option Exercise	13.90	7,500	104,250	201,101	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Sale	59.26	7,500	444,450	193,601	Feb 20 08:17 PM
Chi Michael	Officer	Feb 19 '25	Proposed Sale	59.26	7,500	444,450		Feb 19 10:16 AM
Boughton Soleil	Officer	Feb 18 '25	Proposed Sale	60.69	4,152	251,985		Feb 18 11:22 AM
Dudum Andrew	Officer	Feb 18 '25	Proposed Sale	58.24	175,661	10,230,058		Feb 18 11:10 AM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Option Exercise	0.40	67,687	27,075	774,559	Feb 14 04:49 PM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Sale	44.71	67,687	3,026,624	706,872	Feb 14 04:49 PM
Melissa Baird	Officer	Feb 12 '25	Proposed Sale	46.34	67,687	3,136,616		Feb 12 04:36 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Feb 11 04:16 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Sale	43.28	7,259	314,170	193,601	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Option Exercise	5.01	6,437	32,249	119,370	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Sale	43.01	11,581	498,100	107,789	Feb 11 04:16 PM
Chi Michael	Officer	Feb 10 '25	Proposed Sale	43.28	7,259	314,170		Feb 10 12:09 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Option Exercise	5.01	6,437	32,249	124,514	Feb 05 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Sale	38.92	11,581	450,730	112,933	Feb 05 04:31 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Option Exercise	2.43	100,000	243,000	127,918	Feb 04 04:26 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Sale	35.22	100,000	3,522,300	27,918	Feb 04 04:26 PM
Boughton Soleil	Chief Legal Officer	Feb 03 '25	Sale	35.30	4,153	146,601	161,497	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Option Exercise	11.53	2,054	23,683	195,655	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Sale	35.30	2,054	72,506	193,601	Feb 04 04:25 PM
Boughton Soleil	Officer	Feb 03 '25	Proposed Sale	35.30	4,153	146,601		Feb 03 11:11 AM
Chi Michael	Officer	Feb 03 '25	Proposed Sale	35.30	2,054	72,506		Feb 03 11:11 AM
Dudum Andrew	Officer	Jan 31 '25	Proposed Sale	35.22	100,000	3,522,297		Jan 31 10:43 AM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Option Exercise	5.01	17,304	86,693	210,905	Jan 24 05:20 PM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Sale	31.00	17,304	536,424	193,601	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Option Exercise	2.43	27,098	65,848	55,016	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Sale	30.08	27,098	815,029	27,918	Jan 24 05:20 PM
Chi Michael	Officer	Jan 24 '25	Proposed Sale	31.00	17,304	536,424		Jan 24 09:53 AM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Option Exercise	5.01	50,000	250,500	219,803	Jan 23 04:32 PM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Sale	29.90	54,153	1,619,108	165,650	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Option Exercise	0.40	67,687	27,075	774,559	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Sale	29.35	67,687	1,986,731	706,872	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Option Exercise	13.90	306	4,253	193,907	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Sale	28.68	306	8,776	193,601	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Option Exercise	2.43	14,269	34,674	42,187	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Option Exercise	2.43	300	729	28,218	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Sale	30.08	14,269	429,184	27,918	Jan 23 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience